The Region 4 Stork (R4S) Collaborative Project - Insights
This is a 6-part series describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S.
The Region 4 Stork (R4S) Collaborative Project - Insights
This is a 6-part series describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S.
Skip to Content MayoACCESS MayoLINK...
Mayo Clinic Labs @Work: Connie Ohnstad - Insights
Connie Ohnstad is the supervisor for Mayo Clinic Laboratories Inventory, which includes Mayo Clinic Laboratories Packaging and Specimen Kit Orders (SKO). Connie wears many hats as a supervisor at MCL, and she has a long history with Mayo...
MCL @Work: Amy Turunen - Insights
As the creative director for Mayo Clinic Laboratories, Amy Turunen finds that each day brings unique creative opportunities and marketing projects. Through her design work and creative direction, Amy helps to curate testing awareness and...
Mayo Clinic Labs @Work: Todd Walker - Insights
Todd Walker is a laboratory supervisor for Mayo Clinic Laboratories, Specimen Operations, where he helps lead the department that serves as the gateway between collecting and delivering specimens and getting them processed. Todd credits his...
Mayo Clinic Labs @Work: Meredith Clark - Insights
As a bid coordinator, Meredith Clark’s work helps expand testing capabilities for Mayo Clinic Laboratories clients, so they can offer the right test at the right time for the right patient.
Mucopolysaccharidosis type I (MPS I) is a rare genetic disorder that typically presents with progressive multisystem involvement in early childhood. This condition results from the deficiency of the enzyme, alpha-L-iduronidase (IDUA), which...
Applying the Staffing-to-Workload Methodology: Identifying Daily Indirect Effort Needs - Insights
Mike Baisch, Principal Systems Engineer at Mayo Clinic, demonstrates how daily indirect effort tasks contribute to staffing plans and needs in the staffing-to-workload methodology.
The prostate health index or phi test reduces the need for prostate cancer biopsies by 30 percent.